GLP1R and atherosclerosis: Multiple studies have shown that GLP-1 receptor agonists, including natural GLP-1, exenatide, and liraglutide, can reduce monocyte vascular adhesion by reducing monocyte adhesion and macrophage aggregation, thereby improving cardiac function and reducing atherosclerosis in the blood vessels of atherosclerotic mice [11,12].